Liquid biopsy in 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer

Nature Reviews Gastroenterology and Hepatology

Volumn 14, Issue 2, 2017, Pages 73-74

  Pantel, Klaus ^a   Alix Panabières, Catherine ^b,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; CETUXIMAB; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PANITUMUMAB; TRAMETINIB; UNCLASSIFIED DRUG; CIRCULATING TUMOR DNA;

BLOOD ANALYSIS; CANCER PROGNOSIS; CANCER RESISTANCE; CIRCULATING TUMOR CELL; COLON CANCER; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DRUG MONITORING; EARLY CANCER DIAGNOSIS; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; LIQUID BIOPSY; LIVER METASTASIS; MOLECULARLY TARGETED THERAPY; ONCOGENE K RAS; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PROGRESSION FREE SURVIVAL; SHORT SURVEY; STOMACH CANCER; TUMOR RECURRENCE; GASTROINTESTINAL TUMOR; TUMOR EMBOLISM;

CIRCULATING TUMOR DNA; GASTROINTESTINAL NEOPLASMS; HUMANS; LIQUID BIOPSY; NEOPLASTIC CELLS, CIRCULATING;

EID: 85009787005     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2016.198     Document Type: Short Survey

References (10)

1. Pantel, K. & Alix-Panabières, C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol. Med. 16, 398-406 (2010).
2. Joosse, S. A. & Pantel, K. Tumor-educated platelets as liquid biopsy in cancer patients. Cancer Cell 28, 552-554 (2015).
3. Diaz, L. A. Jr & Bardelli, A. Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol. 32, 579-586 (2014).
4. Alix-Panabières, C. & Pantel, K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov. 6, 479-491 (2016).
5. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
6. Russo, M. et al. Tumor heterogeneity and lesionspecific response to targeted therapy in colorectal cancer. Cancer Discov. 6, 147-153 (2016).
7. Tie, J. et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci. Transl. Med. 8, 346ra92 (2016).
8. Li, Y. et al. Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer. Br. J. Cancer 114, 138-145 (2016).
9. Cayrefourcq, L. et al. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res. 75, 892-901 (2015).
10. Alix-Panabières, C. et al. Molecular portrait of metastasis-competent circulating tumor cells in colon cancer reveals the crucial role of genes regulating energy metabolism and DNA repair. Clin. Chem. http://dx.doi.org/10.1373/clinchem.2016.263582 (2016).